MELBOURNE () – An Australian court on Friday overturned Johnson & Johnson’s ruling against a ruling that its Ethicon subsidiary deceived patients and surgeons over the risk of implanting pelvic mesh.
A full bench of the Federal Court of Australia upheld a federal court judge’s November 2019 decision finding that Ethicon sold implants used to treat urinary incontinence and pelvic organ prolsus, without warning women of the serious risks and that he was negligent, rushing products on the market before appropriate examination.
J&J launched the verdict last year after it was ordered by three women who led the class action to pay a total of $ 2.6 million ($ 2 million) plus legal costs as compensation. More than 1,350 women are in the group action.
“The decision on the lawsuit paves the way for securing compensation for all members of the group represented by the applicants in the coming months,” a statement from Shine Justice, which led the class action lawsuit, said.
J&J said on Friday that it was reviewing the decision and considering options.
“Ethicon believes it has acted ethically and responsibly in the research, development and supply of its transvaginal mesh products and has communicated the benefits and risks to physicians and patients in Australia in an appropriate and responsible manner,” the company said in an email.
She has faced similar lawsuits in the United States, Canada and Europe. In October 2019, he agreed to pay nearly $ 117 million to settle claims in 41 U.S. states and the District of Columbia.
($ 1 = A $ 1.2985)